EGFR and cancer: Up to 70% of TNBC express the epidermal growth factor receptor (EGFR), a tyrosine kinase receptor of the ErbB family, which is abnormally activated in many epithelial tumors11, thus making EGFR a promising target for specific delivery of anti-cancer drugs.